Today, Vertex Pharmaceuticals Inc. released the initial Phase 3 clinical trial data for one of two next-generation, triple-combination modulators currently being tested.
Site Search
Showing 1 - 10 of 48 results
News
|
Nov. 27, 2018
|
3 min read
A new drug intended to make it easier to clear mucus from the lungs of people with cystic fibrosis showed promising results in a Phase 2 clinical trial. The drug, called SPX-101, blocks the overactive sodium channels that line CF lung cells.
News
|
June 7, 2018
|
2 min read
Galapagos and Cystic Fibrosis Foundation Therapeutics Sign €1.3 million* Agreement
Press Release
|
April 14, 2005
|
4 min read
Cystic Fibrosis Foundation Therapeutics to Provide Alnylam with $1.5 Million in Funding for Discovery Efforts
Press Release
|
March 16, 2005
|
5 min read
Press Release
|
Jan. 12, 2006
|
6 min read
Press Release
|
Feb. 14, 2006
|
3 min read
News
|
March 2, 2009
|
1 min read
Press Release
|
Jan. 23, 2008
|
6 min read
Press Release
|
July 8, 2008
|
5 min read
News
|
Aug. 1, 2008
|
1 min read